© 1993 by Oxford University Press
Journal of the National Cancer Institute, Vol. 85, No. 20, 1644-1656,
October 20, 1993
© 1993 Oxford University Press
Report of the International Workshop on Screening for Breast Cancer
Annals of Internal Medicine, American College of Physicians Philadelphia, Pa
Department of Radiology, Dartmouth-Hitchcock Medical Center Lebanon, N.H.
University of North Carolina School of Medicine Chapel Hill
Duke Comprehensive Cancer Center Durham, N.C.
Department of Health Policy and Management, Johns Hopkins School of Hygiene and Public Health Baltimore, Md
Correspondence to:American College of Physicians, Independence Mall West, Sixth St. at Race, Philadelphia, PA 19106-1572.
Background: Over the past 30 years, eight major randomized controlled trials of breast cancer screening with mammography and/or clinical breast examination have been conducted. Results from several trials have been updated during the past year, and initial results of three other trials have been reported. Purpose: The National Cancer Institute held an International Workshop on Screening for Breast Cancer in February 1993 to conduct a thorough and objective critical review of the world's most recent clinical trial data on breast cancer screening, consider the new evidence, assess the current state of knowledge, and identify issues needing further research. Methods: Investigators representing the eight randomized controlled trials of breast cancer screening in women aged 4074 presented published and unpublished data. Evidence relating to the effectiveness of breast cancer screening in different age groups, especially women aged 4049, was presented. Results: For women aged 4049, randomized controlled trials consistently demonstrated no benefit from screening in the first 57 years after study entry. A meta-analysis of six trials found a relative risk of 1.08 (95% confidence interval = 0.851.39) after 7 years' follow-up. After 1012 years of follow-up, none of four trials have found a statistically significant benefit in mortality; a combined analysis of Swedish studies showed a statistically insignificant 13% decrease in mortality at 12 years. Only one trial (Health Insurance Plan) has data beyond 12 years of follow-up, and results show a 25% decrease in mortality at 1018 years. Statistical significance of this result is disputed, however. In women aged 5069, all studies show mortality reductions; three of four studies show reductions of about 30% at 1012 years after study entry. Results from two of these trials were statistically significant. Too few women over age 70 have been included in studies for adequate analysis. Conclusions: For women aged 4049, randomized controlled trials of breast cancer screening show no benefit 57 years after entry. At 1012 years, benefit is uncertain and, if present, marginal; thereafter, it is unknown. For women aged 5069, screening reduces breast cancer mortality by about a third. Currently available data for women age 70 or older are inadequate to judge the effectiveness of screening. Implications: Randomized trials have provided stronger scientific evidence regarding the effectiveness of screening for breast cancer than for any other cancer. However, much still needs to be learned. Periodic gatherings of scientists in the field should speed the process. [J Natl Cancer Inst 85: 16441656, 1993]
This article has been cited by other articles:
![]() |
A. M. Chiarelli, V. Majpruz, P. Brown, M. Theriault, R. Shumak, and V. Mai The Contribution of Clinical Breast Examination to the Accuracy of Breast Screening J Natl Cancer Inst, September 16, 2009; 101(18): 1236 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Auvinen, J. Raitanen, S. Moss, H. J. de Koning, J. Hugosson, T. Tammela, M. Roobol, H. Lilja, and M. Hakama Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands Cancer Epidemiol. Biomarkers Prev., July 1, 2009; 18(7): 2000 - 2005. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Moy, F. Ponzo, M. E. Noz, G. Q. Maguire Jr., A. D. Murphy-Walcott, A. E. Deans, M. T. Kitazono, L. Travascio, and E. L. Kramer Improving Specificity of Breast MRI Using Prone PET and Fused MRI and PET 3D Volume Datasets J. Nucl. Med., April 1, 2007; 48(4): 528 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Bradbury and O. I. Olopade In Reply J. Clin. Oncol., February 10, 2007; 25(5): 605 - 605. [Full Text] [PDF] |
||||
![]() |
C. D. Atkins Potential Hazards of Mammography J. Clin. Oncol., February 10, 2007; 25(5): 604 - 604. [Full Text] [PDF] |
||||
![]() |
W. T. Yang, C.-J. Lai, G. J. Whitman, W. A. Murphy Jr., M. J. Dryden, A. C. Kushwaha, A. A. Sahin, D. Johnston, P. J. Dempsey, and C. C. Shaw Comparison of full-field digital mammography and screen-film mammography for detection and characterization of simulated small masses. Am. J. Roentgenol., December 1, 2006; 187(6): W576 - W581. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Burnside, D. L. Rubin, J. P. Fine, R. D. Shachter, G. A. Sisney, and W. K. Leung Bayesian Network to Predict Breast Cancer Risk of Mammographic Microcalcifications and Reduce Number of Benign Biopsy Results: Initial Experience Radiology, September 1, 2006; 240(3): 666 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bradbury and O. I. Olopade The Case for Individualized Screening Recommendations for Breast Cancer J. Clin. Oncol., July 20, 2006; 24(21): 3328 - 3330. [Full Text] [PDF] |
||||
![]() |
C. P. Haakenson, K. S. Vickers, S. S. Cha, C. M. Vachon, J. M. Thielen, K. J. Kircher, and S. Pruthi Efficacy of a Simple, Low-Cost Educational Intervention in Improving Knowledge About Risks and Benefits of Screening Mammography Mayo Clin. Proc., June 1, 2006; 81(6): 783 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Chew, J. Mandelbaum-Schmid, and S. K. Gao Can Health Journalists Bridge the State-of-the-Science Gap in Mammography Guidelines? Science Communication, March 1, 2006; 27(3): 331 - 351. [Abstract] [PDF] |
||||
![]() |
L. Rosenberg, L. A. Wise, J. R. Palmer, N. J. Horton, and L. L. Adams-Campbell A Multilevel Study of Socioeconomic Predictors of Regular Mammography Use Among African-American Women Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2628 - 2633. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Kopans Bias in the Medical Journals: A Commentary Am. J. Roentgenol., July 1, 2005; 185(1): 176 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Elmore, K. Armstrong, C. D. Lehman, and S. W. Fletcher Screening for Breast Cancer JAMA, March 9, 2005; 293(10): 1245 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Brem, J. W. Hoffmeister, G. Zisman, M. P. DeSimio, and S. K. Rogers A Computer-Aided Detection System for the Evaluation of Breast Cancer by Mammographic Appearance and Lesion Size Am. J. Roentgenol., March 1, 2005; 184(3): 893 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. W. Brawley and B. S. Kramer Cancer Screening in Theory and in Practice J. Clin. Oncol., January 10, 2005; 23(2): 293 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Yabroff, N. Breen, S. W. Vernon, H. I. Meissner, A. N. Freedman, and R. Ballard-Barbash What Factors Are Associated with Diagnostic Follow-Up after Abnormal Mammograms? Findings from a U.S. National Survey Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 723 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Barton, D. S. Morley, S. Moore, J. D. Allen, K. P. Kleinman, K. M. Emmons, and S. W. Fletcher Decreasing Women's Anxieties After Abnormal Mammograms: A Controlled Trial J Natl Cancer Inst, April 7, 2004; 96(7): 529 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Y. Takahashi, H. R. Okhravi, L. S. Lim, and M. J. Kasten Preventive Health Care in the Elderly Population: A Guide for Practicing Physicians Mayo Clin. Proc., March 1, 2004; 79(3): 416 - 427. [Abstract] [PDF] |
||||
![]() |
P. C Gotzsche On the benefits and harms of screening for breast cancer Int. J. Epidemiol., February 1, 2004; 33(1): 56 - 64. [Full Text] [PDF] |
||||
![]() |
P. Fox, P. Arnsberger, D. Owens, B. Nussey, X. Zhang, J. M. Golding, F. Tabnak, and R. Otero-Sabogal Patient and Clinical Site Factors Associated With Rescreening Behavior Among Older Multiethnic, Low-Income Women Gerontologist, February 1, 2004; 44(1): 76 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gurevich, G. M. Devins, C. Wilson, D. McCready, C. R. Marmar, and G. M. Rodin Stress Response Syndromes in Women Undergoing Mammography: A Comparison of Women With and Without a History of Breast Cancer Psychosom Med, January 1, 2004; 66(1): 104 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Kopans, B. Monsees, and S. A. Feig Screening for "Cancer": When is it Valid?--Lessons from the Mammography Experience Radiology, November 1, 2003; 229(2): 319 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Brem, J. Baum, M. Lechner, S. Kaplan, S. Souders, L. G. Naul, and J. Hoffmeister Improvement in Sensitivity of Screening Mammography with Computer-Aided Detection: A Multiinstitutional Trial Am. J. Roentgenol., September 1, 2003; 181(3): 687 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vranjesevic, C. Schiepers, D. H. Silverman, A. Quon, J. Villalpando, M. Dahlbom, M. E. Phelps, and J. Czernin Relationship Between 18F-FDG Uptake and Breast Density in Women with Normal Breast Tissue J. Nucl. Med., August 1, 2003; 44(8): 1238 - 1242. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Harvey, B. Geller, R. G. Oppenheimer, M. Pinet, L. Riddell, and B. Garra Increase in Cancer Detection and Recall Rates with Independent Double Interpretation of Screening Mammography Am. J. Roentgenol., May 1, 2003; 180(5): 1461 - 1467. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Fletcher and J. G. Elmore Mammographic Screening for Breast Cancer N. Engl. J. Med., April 24, 2003; 348(17): 1672 - 1680. [Full Text] [PDF] |
||||
![]() |
D. A. Mankoff, L. K. Dunnwald, and P. Kinahan Are We Ready for Dedicated Breast Imaging Approaches? J. Nucl. Med., April 1, 2003; 44(4): 594 - 595. [Full Text] [PDF] |
||||
![]() |
D. B. Kopans The Most Recent Breast Cancer Screening Controversy About Whether Mammographic Screening Benefits Women at Any Age: Nonsense and Nonscience Am. J. Roentgenol., January 1, 2003; 180(1): 21 - 26. [Full Text] [PDF] |
||||
![]() |
Y. R. Parisky, A. Sardi, R. Hamm, K. Hughes, L. Esserman, S. Rust, and K. Callahan Efficacy of Computerized Infrared Imaging Analysis to Evaluate Mammographically Suspicious Lesions Am. J. Roentgenol., January 1, 2003; 180(1): 263 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Randolph, J. S. Goodwin, J. D. Mahnken, and J. L. Freeman Regular Mammography Use Is Associated with Elimination of Age-Related Disparities in Size and Stage of Breast Cancer at Diagnosis Ann Intern Med, November 19, 2002; 137(10): 783 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Pearson, P. A. Ganz, K. McGuigan, J. R. Malin, J. Adams, and K. L. Kahn The Case Identification Challenge in Measuring Quality of Cancer Care J. Clin. Oncol., November 1, 2002; 20(21): 4353 - 4360. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Kolb, J. Lichy, and J. H. Newhouse Comparison of the Performance of Screening Mammography, Physical Examination, and Breast US and Evaluation of Factors that Influence Them: An Analysis of 27,825 Patient Evaluations Radiology, October 1, 2002; 225(1): 165 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Miller, T. To, C. J. Baines, and C. Wall The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years Ann Intern Med, September 3, 2002; 137(5_Part_1): 305 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Humphrey, M. Helfand, B. K.S. Chan, and S. H. Woolf Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, September 3, 2002; 137(5_Part_1): 347 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jacobellis and G. Cutter Mammography Screening and Differences in Stage of Disease by Race/Ethnicity Am J Public Health, July 1, 2002; 92(7): 1144 - 1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Jones and J. A. Chilton Impact of Breast Cancer on African American Women: Priority Areas for Research in the Next Decade Am J Public Health, April 1, 2002; 92(4): 539 - 542. [Abstract] [Full Text] |
||||
![]() |
M. Summerhayes Capecitabine: a novel, orally administered, tumour-activated treatment for breast cancer Journal of Oncology Pharmacy Practice, March 1, 2002; 8(1): 1 - 17. [Abstract] [PDF] |
||||
![]() |
J. Wells, P. Marshall, B. Crawley, and K. Dickersin Newspaper Reporting of Screening Mammography Ann Intern Med, December 18, 2001; 135(12): 1029 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stefanek, L. Hartmann, and W. Nelson Risk-Reduction Mastectomy: Clinical Issues and Research Needs J Natl Cancer Inst, September 5, 2001; 93(17): 1297 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Olivotto, C. Bancej, V. Goel, J. Snider, R. G. McAuley, B. Irvine, L. Kan, D. Mirsky, M. J. Sabine, R. McGilly, et al. Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces Can. Med. Assoc. J., August 1, 2001; 165(3): 277 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
C J M de Wolf, G Q. della Rovere, R. Warren, A B Miller, and C J Baines Detection of breast cancer BMJ, March 31, 2001; 322(7289): 792a - 792. [Full Text] |
||||
![]() |
M. Summerhayes Trastuzumab in the treatment of HER2 positive breast cancer Journal of Oncology Pharmacy Practice, March 1, 2001; 7(1): 9 - 25. [Abstract] [PDF] |
||||
![]() |
C.T.M. Brekelmans, C. Seynaeve, C.C.M. Bartels, M.M.A. Tilanus-Linthorst, E.J. Meijers-Heijboer, C.M.G. Crepin, A.N. van Geel, M. Menke, L.C. Verhoog, A. van den Ouweland, et al. Effectiveness of Breast Cancer Surveillance in BRCA1/2 Gene Mutation Carriers and Women With High Familial Risk J. Clin. Oncol., February 15, 2001; 19(4): 924 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Maxwell, C. M. Bancej, and J. Snider Predictors of mammography use among Canadian women aged 50-69: findings from the 1996/97 National Population Health Survey Can. Med. Assoc. J., February 1, 2001; 164(3): 329 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Khalkhali, J. Villanueva-Meyer, S. L. Edell, J. L. Connolly, S. J. Schnitt, J. K. Baum, M. J. Houlihan, R. M. Jenkins, and S. B. Haber Diagnostic Accuracy of 99mTc-Sestamibi Breast Imaging: Multicenter Trial Results J. Nucl. Med., December 1, 2000; 41(12): 1973 - 1979. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Poplack, A. N. Tosteson, M. R. Grove, W. A. Wells, and P. A. Carney Mammography in 53,803 Women from the New Hampshire Mammography Network Radiology, December 1, 2000; 217(3): 832 - 840. [Abstract] [Full Text] |
||||
![]() |
I. Mittra, M. Baum, H. Thornton, and J. Houghton Is clinical breast examination an acceptable alternative to mammographic screening? BMJ, October 28, 2000; 321(7268): 1071 - 1073. [Full Text] |
||||
![]() |
N. Avril, C. A. Rose, M. Schelling, J. Dose, W. Kuhn, S. Bense, W. Weber, S. Ziegler, H. Graeff, and M. Schwaiger Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations J. Clin. Oncol., October 20, 2000; 18(20): 3495 - 3502. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Christiansen, F. Wang, M. B. Barton, W. Kreuter, J. G. Elmore, A. E. Gelfand, and S. W. Fletcher Predicting the Cumulative Risk of False-Positive Mammograms J Natl Cancer Inst, October 18, 2000; 92(20): 1657 - 1666. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Miller, T. To, C. J. Baines, and C. Wall Canadian National Breast Screening Study-2: 13-Year Results of a Randomized Trial in Women Aged 50-59 Years J Natl Cancer Inst, September 20, 2000; 92(18): 1490 - 1499. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Gotay, C. M. Moinpour, S. Moody-Thomas, E. R. Gritz, K. S. Albain, E. DeAntoni, L. Hansen, and P. A. Ganz Behavioral Science Research in the Cooperative Group Setting: the Southwest Oncology Group Experience J Natl Cancer Inst, September 6, 2000; 92(17): 1381 - 1387. [Full Text] [PDF] |
||||
![]() |
D. M. Cummings, L. Whetstone, A. Shende, and D. Weismiller Predictors of Screening Mammography: Implications for Office Practice Arch Fam Med, September 1, 2000; 9(9): 870 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Mandelson, N. Oestreicher, P. L. Porter, D. White, C. A. Finder, S. H. Taplin, and E. White Breast Density as a Predictor of Mammographic Detection: Comparison of Interval- and Screen-Detected Cancers J Natl Cancer Inst, July 5, 2000; 92(13): 1081 - 1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Bobo, N. C. Lee, and S. F. Thames Findings From 752 081 Clinical Breast Examinations Reported to a National Screening Program From 1995 Through 1998 J Natl Cancer Inst, June 21, 2000; 92(12): 971 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R Sussman Mammography screening for breast cancer in women under 50 years Fam. Pract., June 1, 2000; 17(3): 272 - 275. [Full Text] [PDF] |
||||
![]() |
S. Y. Moody-Ayers, C. K. Wells, and A. R. Feinstein "Benign" Tumors and "Early Detection" in Mammography-Screened Patients of a Natural Cohort With Breast Cancer Arch Intern Med, April 24, 2000; 160(8): 1109 - 1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Goodson III, D. H. Moore II, F. M. Hall, D. B. Kopans, M. B. Barton, S. W. Fletcher, and R. Harris Clinical Breast Examination for Detecting Breast Cancer JAMA, April 5, 2000; 283(13): 1687 - 1689. [Full Text] [PDF] |
||||
![]() |
R. T. Penson, M. V. Seiden, K. M. Shannon, M. L. Lubratovich, M. Roche, B. A. Chabner, and T. J. Lynch Jr. Communicating Genetic Risk: Pros, Cons, and Counsel Oncologist, April 1, 2000; 5(2): 152 - 161. [Abstract] [Full Text] |
||||
![]() |
S. A. Feig Age-related Accuracy of Screening Mammography: How Should It Be Measured? Radiology, March 1, 2000; 214(3): 633 - 640. [Full Text] |
||||
![]() |
R. E. Anderson Billions for Defense: The Pervasive Nature of Defensive Medicine Arch Intern Med, November 8, 1999; 159(20): 2399 - 2402. [Full Text] [PDF] |
||||
![]() |
E. J. Ludman, S. J. Curry, D. Meyer, and S. H. Taplin Implementation of Outreach Telephone Counseling to Promote Mammography Participation Health Educ Behav, October 1, 1999; 26(5): 689 - 702. [Abstract] [PDF] |
||||
![]() |
J. S. Mandelblatt and K. R. Yabroff Effectiveness of Interventions Designed to Increase Mammography Use: A Meta-Analysis of Provider-targeted Strategies Cancer Epidemiol. Biomarkers Prev., September 1, 1999; 8(9): 759 - 767. [Abstract] [Full Text] |
||||
![]() |
M. L. Burman, S. H. Taplin, D. F. Herta, and J. G. Elmore Effect of False-Positive Mammograms on Interval Breast Cancer Screening in a Health Maintenance Organization Ann Intern Med, July 6, 1999; 131(1): 1 - 6. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Antman and S. Shea Screening Mammography Under Age 50 JAMA, April 28, 1999; 281(16): 1470 - 1472. [Full Text] [PDF] |
||||
![]() |
C. Lerman, C. Hughes, J. L. Benkendorf, B. Biesecker, J. Kerner, J. Willison, N. Eads, D. Hadley, and J. Lynch Racial Differences in Testing Motivation and Psychological Distress following Pretest Education for BRCA1 Gene Testing Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 361 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Armstrong ``Controversies in epidemiology'', teaching causality in context at the University at Albany, School of Public Health Scand J Public Health, April 1, 1999; 27(2): 81 - 84. [Abstract] [PDF] |
||||
![]() |
N. C. Dolan, M. McGrae McDermott, M. Morrow, L. Venta, and G. J. Martin Impact of Same-Day Screening Mammography Availability: Results of a Controlled Clinical Trial Arch Intern Med, February 22, 1999; 159(4): 393 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Kopans The Breast Cancer Screening Controversy and the National Institutes of Health Consensus Development Conference on Breast Cancer Screening for Women Ages 40–49 Radiology, January 1, 1999; 210(1): 4 - 9. [Full Text] |
||||
![]() |
J. Wells, G. J Ong, and H. Bastian Mammography and the politics of randomised controlled trials • Commentary: The public has a role to play in translating evidence into practice • Commentary: Why are researchers surprised when there is not a smooth transition from research into practice? BMJ, October 31, 1998; 317(7167): 1224 - 1230. [Full Text] |
||||
![]() |
J. G. Elmore, M. B. Barton, V. M. Moceri, S. Polk, P. J. Arena, and S. W. Fletcher Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast Examinations N. Engl. J. Med., April 16, 1998; 338(16): 1089 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Skinner, R. K. Sykes, B. S. Monsees, D. A. Andriole, C. L. Arfken, and E. B. Fisher Learn, Share, and Live: Breast Cancer Education for Older, Urban Minority Women Health Educ Behav, February 1, 1998; 25(1): 60 - 78. [Abstract] [PDF] |
||||
![]() |
S. H. Woolf and R. S. Lawrence Preserving Scientific Debate and Patient Choice: Lessons From the Consensus Panel on Mammography Screening JAMA, December 17, 1997; 278(23): 2105 - 2108. [Abstract] [PDF] |
||||
![]() |
B. E. Weber and B. M. Reilly Enhancing Mammography Use in the Inner City: A Randomized Trial of Intensive Case Management Arch Intern Med, November 10, 1997; 157(20): 2345 - 2349. [Abstract] [PDF] |
||||
![]() |
S. W. Fletcher Whither Scientific Deliberation in Health Policy Recommendations? -- Alice in the Wonderland of Breast-Cancer Screening N. Engl. J. Med., April 17, 1997; 336(16): 1180 - 1183. [Full Text] |
||||
![]() |
S. Fletcher Breast cancer screening in women aged under 50 BMJ, March 15, 1997; 314(7083): 764 - 764. [Full Text] |
||||
![]() |
K. Kerlikowske, D. Grady, J. Barclay, E. A. Sickles, and V. Ernster Effect of Age, Breast Density, and Family History on the Sensitivity of First Screening Mammography JAMA, July 3, 1996; 276(1): 33 - 38. [Abstract] [PDF] |
||||
![]() |
S. Bhargava, D J Watmough, F. Syed, A. Mernon, and F. Gharbawy High detection rates do not necessarily lead to lower mortality BMJ, February 24, 1996; 312(7029): 509b - 509. [Full Text] |
||||
![]() |
K. K. Lindfors and C. J. Rosenquist The Cost-effectiveness of Mammographic Screening Strategies JAMA, September 20, 1995; 274(11): 881 - 884. [Abstract] [PDF] |
||||
![]() |
R. H. Fletcher and S. W. Fletcher General Internal Medicine JAMA, June 7, 1995; 273(21): 1681 - 1682. [Abstract] [PDF] |
||||
![]() |
C. B J Woodman, A. G Threlfall, C. R M Boggis, and P. Prior Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region BMJ, January 28, 1995; 310(6974): 224 - 226. [Abstract] [Full Text] |
||||
![]() |
H. Kattlove, A. Liberati, E. Keeler, and R. H. Brook Benefits and Costs of Screening and Treatment for Early Breast Cancer: Development of a Basic Benefit Package JAMA, January 11, 1995; 273(2): 142 - 148. [Abstract] [PDF] |
||||
![]() |
K. Kerlikowske, D. Grady, S. M. Rubin, C. Sandrock, and V. L. Ernster Efficacy of Screening Mammography: A Meta-analysis JAMA, January 11, 1995; 273(2): 149 - 154. [Abstract] [PDF] |
||||
![]() |
D. M. Eddy Rationing Resources While Improving Quality: How to Get More for Less JAMA, September 14, 1994; 272(10): 817 - 824. [Abstract] [PDF] |
||||
![]() |
H. J. Sox Preventive Health Services in Adults N. Engl. J. Med., June 2, 1994; 330(22): 1589 - 1595. [Full Text] |
||||
![]() |
R. G. Evens Radiology JAMA, June 1, 1994; 271(21): 1714 - 1715. [Abstract] [PDF] |
||||
![]() |
D. B. Kopans The Use of Mammography for Screening JAMA, April 6, 1994; 271(13): 982 - 982. [Abstract] [PDF] |
||||
![]() |
J. Aisner Breast Cancer Screening for Elderly Women-Reply JAMA, January 19, 1994; 271(3): 191 - 192. [Abstract] [PDF] |
||||
![]() |
K. Kerlikowske, D. Grady, J. Barclay, E. A. Sickles, A. Eaton, and V. Ernster Positive Predictive Value of Screening Mammography by Age and Family History of Breast Cancer JAMA, November 24, 1993; 270(20): 2444 - 2450. [Abstract] [PDF] |
||||























